Audentes Therapeutics, Inc.
Audentes Therapeutics, Inc. (BOLD) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 310 transactions totaling $86.9M, demonstrating a bearish sentiment with -$34.5M in net insider flow. The most recent transaction on Jan 23, 2026 involved a transaction of 140,000 shares valued at $0.
BOLD Insider Activity Summary
Who Is Buying BOLD Stock?
No significant insider buying has been recorded for BOLD in the recent period.
Who Is Selling BOLD Stock?
No significant insider selling has been recorded for BOLD in the recent period.
Is Audentes Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BOLD is bearish with an Insider Alignment Score of 30/100 and a net flow of -$34.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
BOLD Frequently Asked Questions
Understanding BOLD Insider Activity
Insider trading at Audentes Therapeutics, Inc. (BOLD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading BOLD stock, having executed 310 transactions in the past 90 days. The most active insider is Matthew R. Patterson (Executive), who has made 55 transactions totaling $35.2M.
Related Tools
Track Audentes Therapeutics, Inc. Insider Activity
Get notified when executives and directors at BOLD file new Form 4 transactions